Previous close | 218.70 |
Open | 224.10 |
Bid | 223.60 x 0 |
Ask | 230.30 x 0 |
Day's range | 224.10 - 224.10 |
52-week range | 118.00 - 296.00 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 07 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.
ResMed's (RMD) fiscal 2024 third-quarter performance reflects another strong period of execution across the entire business, resulting in impressive top and bottom-line growth.
ICON's (ICLR) first-quarter 2024 performance is driven by its efficient service delivery and strong cost control.